CH475997A - Verfahren zur Herstellung einer antibiotisch wirksamen Substanz - Google Patents
Verfahren zur Herstellung einer antibiotisch wirksamen SubstanzInfo
- Publication number
- CH475997A CH475997A CH1683365A CH1683365A CH475997A CH 475997 A CH475997 A CH 475997A CH 1683365 A CH1683365 A CH 1683365A CH 1683365 A CH1683365 A CH 1683365A CH 475997 A CH475997 A CH 475997A
- Authority
- CH
- Switzerland
- Prior art keywords
- production
- antibiotic substance
- antibiotic
- substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US416599A US3361742A (en) | 1964-12-07 | 1964-12-07 | 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH475997A true CH475997A (de) | 1969-07-31 |
Family
ID=23650586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1683365A CH475997A (de) | 1964-12-07 | 1965-12-07 | Verfahren zur Herstellung einer antibiotisch wirksamen Substanz |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3361742A (de) |
| AT (1) | AT269350B (de) |
| BE (1) | BE673376A (de) |
| BR (1) | BR6575537D0 (de) |
| CH (1) | CH475997A (de) |
| DE (1) | DE1467872A1 (de) |
| ES (1) | ES320436A1 (de) |
| FR (1) | FR1553664A (de) |
| GB (1) | GB1092888A (de) |
| NL (1) | NL6515880A (de) |
| SE (1) | SE316136B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3523941A (en) * | 1967-03-06 | 1970-08-11 | Hoffmann La Roche | Benzodiazepine compounds and process for their preparation |
| US3524849A (en) * | 1967-10-27 | 1970-08-18 | Hoffmann La Roche | Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein |
| DE1965304A1 (de) * | 1968-12-30 | 1970-07-23 | Fujisawa Pharmaceutical Co | Benzdiazepinon-Verbindungen und Verfahren zu ihrer Herstellung |
| JPS5279082A (en) * | 1975-12-25 | 1977-07-02 | Green Cross Corp:The | Preparation of anti-tumor compound |
| JPS585916B2 (ja) | 1977-12-27 | 1983-02-02 | 株式会社ミドリ十字 | 新規ベンゾジアゼピン系化合物 |
| CA1214774A (en) * | 1983-02-10 | 1986-12-02 | Yusei Shiraga | Benzodiazepine derivative |
| AUPO470197A0 (en) * | 1997-01-21 | 1997-02-13 | Attfield, Paul Victor | Fluorescent dyes from microorganisms |
| CA2795349C (en) | 2010-04-15 | 2016-11-29 | Seattle Genetics, Inc. | Targeted pyrrolobenzodiazepine conjugates |
| JP5875083B2 (ja) | 2010-04-15 | 2016-03-02 | メディミューン リミテッド | 増殖性疾患治療用ピロロベンゾジアゼピン |
| SG11201400770SA (en) | 2011-09-20 | 2014-04-28 | Spirogen Sarl | Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| CN103997893B (zh) | 2011-10-14 | 2019-04-12 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
| AU2012322932B2 (en) | 2011-10-14 | 2016-11-10 | Medimmune Limited | Pyrrolobenzodiazepines |
| EP2751111B1 (de) | 2011-10-14 | 2017-04-26 | MedImmune Limited | Asymmetrische Bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-on) Derivate zur Behandlung von proliferativen oder Autoimmunerkrankungen |
| EP2906296B1 (de) | 2012-10-12 | 2018-03-21 | ADC Therapeutics SA | Pyrrolobenzodiazepin-antikörper-konjugate |
| RS57694B1 (sr) | 2012-10-12 | 2018-11-30 | Adc Therapeutics Sa | Pirolobenzodiazepin - anti-psma konjugati antitela |
| ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
| EP2906249B1 (de) | 2012-10-12 | 2018-06-27 | MedImmune Limited | Synthese und zwischenprodukte pyrrolobenzodiazepinderivaten zur konjugation |
| HRP20190366T1 (hr) | 2012-10-12 | 2019-04-19 | Medimmune Limited | Pirolobenzodiazepini i njihovi konjugati |
| JP6392765B2 (ja) | 2012-10-12 | 2018-09-19 | エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ | ピロロベンゾジアゼピン−抗体結合体 |
| MX338711B (es) | 2012-10-12 | 2016-04-28 | Medimmune Ltd | Pirrolobenzodiazepinas y conjugados de las mismas. |
| HRP20182129T1 (hr) | 2012-10-12 | 2019-02-08 | Adc Therapeutics Sa | Konjugati protutijelo - pirolobenzodiazepin |
| EP2906297B1 (de) | 2012-10-12 | 2017-12-06 | ADC Therapeutics SA | Pyrrolobenzodiazepin-antikörper-konjugate |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| EP3054983B1 (de) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepin-antikörper-konjugate |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN107148285B (zh) | 2014-11-25 | 2022-01-04 | Adc治疗股份有限公司 | 吡咯并苯并二氮杂䓬-抗体缀合物 |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| RS61795B1 (sr) | 2017-02-08 | 2021-06-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin antitela |
| CN110582505B (zh) | 2017-04-18 | 2021-04-02 | 免疫医疗有限公司 | 吡咯并苯并二氮杂*缀合物 |
| WO2018193102A1 (en) | 2017-04-20 | 2018-10-25 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| CA3064804A1 (en) | 2017-06-14 | 2018-12-20 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-cd19 adc |
| KR102270107B1 (ko) | 2017-08-18 | 2021-06-30 | 메디뮨 리미티드 | 피롤로벤조디아제핀 컨쥬게이트 |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN113631560B (zh) | 2019-03-15 | 2025-02-18 | 麦迪穆有限责任公司 | 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3247187A (en) * | 1963-07-10 | 1966-04-19 | Hoffmann La Roche | Oxidation of 1, 4-benzodiazepines to 1, 4-benzodiazepin-2-ones |
-
1964
- 1964-12-07 US US416599A patent/US3361742A/en not_active Expired - Lifetime
-
1965
- 1965-12-03 FR FR1553664D patent/FR1553664A/fr not_active Expired
- 1965-12-04 DE DE19651467872 patent/DE1467872A1/de active Pending
- 1965-12-06 ES ES0320436A patent/ES320436A1/es not_active Expired
- 1965-12-06 AT AT1097465A patent/AT269350B/de active
- 1965-12-06 GB GB51119/65A patent/GB1092888A/en not_active Expired
- 1965-12-07 NL NL6515880A patent/NL6515880A/xx unknown
- 1965-12-07 BR BR175537/65A patent/BR6575537D0/pt unknown
- 1965-12-07 BE BE673376D patent/BE673376A/xx unknown
- 1965-12-07 CH CH1683365A patent/CH475997A/de not_active IP Right Cessation
- 1965-12-07 SE SE15830/65A patent/SE316136B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE673376A (de) | 1966-04-01 |
| SE316136B (de) | 1969-10-20 |
| GB1092888A (en) | 1967-11-29 |
| ES320436A1 (es) | 1966-05-16 |
| NL6515880A (de) | 1966-06-08 |
| FR1553664A (de) | 1969-01-17 |
| BR6575537D0 (pt) | 1973-09-06 |
| AT269350B (de) | 1969-03-10 |
| US3361742A (en) | 1968-01-02 |
| DE1467872A1 (de) | 1969-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH475997A (de) | Verfahren zur Herstellung einer antibiotisch wirksamen Substanz | |
| CH490309A (de) | Verfahren zur Herstellung substituierter Biphenylessigsäuren | |
| CH478156A (de) | Verfahren zur Herstellung neuartiger Antibiotika | |
| AT275780B (de) | Verfahren zur Herstellung von Sinterkörpern | |
| CH479589A (de) | Verfahren zur Herstellung von Imidazolen | |
| CH473758A (de) | Verfahren zur Herstellung von Trimethylhexamethylendiamin | |
| CH480434A (de) | Verfahren zur Herstellung des Antibiotikums Kasugamycin | |
| AT266313B (de) | Verfahren zur Herstellung einer antikoagulierend wirkenden Substanz | |
| CH475923A (de) | Verfahren zur Herstellung homöoporöser Kohlenstoffkörper | |
| AT259762B (de) | Verfahren zur Herstellung eines Antibioticums | |
| CH454163A (de) | Verfahren zur Herstellung von Polyhalogenphenolen | |
| CH437345A (de) | Verfahren zur Herstellung von cyclischen Äthern | |
| CH468355A (de) | Verfahren zur Herstellung von Isonitrilen | |
| CH454161A (de) | Verfahren zur Herstellung eledoisinwirksamer Undekapeptide | |
| AT260539B (de) | Verfahren zur Herstellung von Schwefel-Harz-Massen | |
| AT255880B (de) | Verfahren zur Herstellung einer Übergußmasse | |
| AT256808B (de) | Verfahren zur Herstellung von ɛ-Caprolactam | |
| CH461498A (de) | Verfahren zur Herstellung substituierter e-Caprolactame | |
| CH472427A (de) | Verfahren zur Herstellung von Antibiotika | |
| AT289090B (de) | Verfahren zur Herstellung von Rhodanverbindungen | |
| CH441355A (de) | Verfahren zur Herstellung von Antibiotika | |
| CH468365A (de) | Verfahren zur Herstellung von Testosteron-Derivaten | |
| AT261896B (de) | Verfahren zur Herstellung von Polyvinylalkoholderivaten | |
| AT266314B (de) | Verfahren zur Herstellung des neuen Antibiotikums Lincomycin B | |
| CH458392A (de) | Verfahren zur Herstellung von Merkaptalen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |